Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. <i>Pharmaceuticals</i> 2022, <i>15</i>, 1400

Podobne zapisy

• Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats
  od: Aliyah Almomen, i wsp.
  Wydane: (2020-09-01)
• Acidifying agents impact erlotinib and gefitinib pharmacokinetic parameters and elevate liver enzymes in Wistar rats
  od: Amsha S. Alsegiani, i wsp.
  Wydane: (2025-10-01)
• Correction: AlRasheed et al. Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats. <i>Pharmaceuticals</i> 2022, <i>15</i>, 1400
  od: Hajer AlRasheed, i wsp.
  Wydane: (2024-12-01)
• Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting
  od: Wang Chun Kwok, i wsp.
  Wydane: (2022-07-01)
• Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study
  od: Ye Jiang, i wsp.
  Wydane: (2018-11-01)